Benjamin Rowlands
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- Ultrasound in Clinical Applications 2
-
- COVID-19 Clinical Research Studies 3
- Journals
- The Lancet (3 papers)Intensive Care Medicine (2 papers)The Lancet Digital Health (1 paper)Cureus (1 paper)
- Partner nations
- United KingdomVietnamNepal
In The Last Decade
Benjamin Rowlands
5 papers receiving 894 citations
Benjamin Rowlands's Hit Papers
Peers
Comparison fields: 5 of 43
- Infectious Diseases 556
- Applied Microbiology and Biotechnology 29
- Internal Medicine 15
- Critical Care and Intensive Care Medicine 9
- Obstetrics and Gynecology 15
Countries citing papers authored by Benjamin Rowlands
This map shows the geographic impact of Benjamin Rowlands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Rowlands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Rowlands more than expected).
Fields of papers citing papers by Benjamin Rowlands
This network shows the impact of papers produced by Benjamin Rowlands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Rowlands. The network helps show where Benjamin Rowlands may publish in the future.
Co-authors
The 2 scholars most cited alongside Benjamin Rowlands, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | 2021 | 213 | |
| 4 | 2022 | 26 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2025 | 0 |
About Benjamin Rowlands
Benjamin Rowlands is a scholar working on Critical Care and Intensive Care Medicine, Infectious Diseases, Physiology, Cardiology and Cardiovascular Medicine and Nuclear Energy and Engineering, having authored 8 papers that have together received 943 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Simulation-Based Education in Healthcare (2 papers), Ultrasound in Clinical Applications (2 papers) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). The work is most often cited by research in Infectious Diseases (556 citations), Applied Microbiology and Biotechnology (29 citations), Internal Medicine (15 citations), Critical Care and Intensive Care Medicine (9 citations) and Obstetrics and Gynecology (15 citations). Benjamin Rowlands has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Frequent co-authors include Natalie A. Cope and Jessica Anne Brown. Their work appears in journals such as The Lancet, Intensive Care Medicine, The Lancet Digital Health and Cureus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.